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Degradation by Stratum Corneum Proteases Prevents
Endogenous RNase Inhibitor from Blocking
Antimicrobial Activities of RNase 5 and RNase 7
Arby Abtin1, Leopold Eckhart1, Michael Mildner1, Minoo Ghannadan1, Ju¨rgen Harder2,
Jens-Michael Schro¨der2 and Erwin Tschachler1,3
The antimicrobial defense of the skin is partially mediated by RNase 7, an abundant ribonuclease of the stratum
corneum (SC). Here, we investigated the expression and regulation of members of the RNase A family and of
the endogenous RNase inhibitor (RI) protein in epidermal keratinocytes (KCs). Reverse transcription-PCR
screening revealed that KCs expressed not only RNase 7 but also RNase 5, which was shown earlier to kill the
yeast Candida albicans, as well as RNase 1, RNase 4, and RI. The mRNA and protein levels of RNase 5, RNase 7,
and RI increased during KC differentiation. When RNase 5 and RNase 7 were incubated with RI in vitro, not only
their ribonucleolytic activities but also their antimicrobial activities were strongly suppressed. Immunochemical
analyses revealed that SC contains RNase 5, whereas RI was not detectable. Unlike recombinant RNase 5,
recombinant RI was degraded when exposed to SC extract. The addition of aprotinin prevented the degradation
of RI, indicating that serine proteases of the SC cleave RI. Taken together, this study adds RNase 5 to the list of
antimicrobial factors present in the SC and suggests that proteases contribute indirectly to the defense function
of the SC by releasing the RI-mediated inhibition of RNase 5 and RNase 7.
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INTRODUCTION
The fact that the surface of human skin contains strong
ribonuclease (RNase) activity is well known (Tabachnick and
Freed, 1961; Steigleder and Raab, 1962). However, the
physiological role of the skin ribonuclease activity and its
control has not yet been characterized in depth. Recently,
RNase 7 was isolated from human stratum corneum (SC), and
was shown to exert antimicrobial activity (Harder and
Schro¨der, 2002).
RNase 7 is a member of the human RNase A superfamily,
which is encoded by a cluster of 13 genes located on
chromosome 14q11.2. Only eight genes (RNASE1–RNASE8)
of this family encode for proteins that are catalytically active
to varying degrees against standard RNA substrates (Dyer and
Rosenberg, 2006). In addition to their ribonuclease activity,
some members of this family such as RNase 2 (eosinophil-
derived neurotoxin), RNase 3 (eosinophil cationic protein),
RNase 5, the above-mentioned RNase 7 and RNase 8 have
antimicrobial properties as well (Lehrer et al., 1989;
Domachowske et al., 1998; Harder and Schro¨der, 2002;
Hooper et al., 2003; Rudolph et al., 2006), indicating a role
in the innate immune defense. RNase 7 is active especially
against Enterococcus faecium, Pseudomonas aeruginosa, and
Pichia pastoris, and to a lesser degree against Propionibacter-
ium acnes and Escherichia coli (Harder and Schro¨der, 2002;
Huang et al., 2007). It has been suggested that the
antimicrobial activity of RNase 7 is due to pore formation
and disruption of the bacterial membrane and is independent
of the ribonuclease activity (Huang et al., 2007). RNase 5,
also known as angiogenin, has been implicated in blood
vessel formation (Fett et al., 1985), but a recent study
revealed an antimicrobial activity of RNase 5, especially
against Candida albicans (Hooper et al., 2003). RNase 5 is
secreted by the reconstructed human epidermis in vitro
(Rendl et al., 2001); however, its contribution to the skin
defense is unknown.
Ribonuclease inhibitor (RI) is a horseshoe-shaped leucine-
rich repeat protein (Kobe and Deisenhofer, 1993), which
constitutes about 0.1% of the total protein in the cytosol of
mammalian cells (Leland and Raines, 2001). Through its
concave cavity, RI binds at a 1:1 stoichiometry to several
members of the RNase A superfamily (Shapiro et al., 1986;
Shapiro and Vallee, 1987; Papageorgiou et al., 1997; Maeda
See related commentary on pg 2091
& 2009 The Society for Investigative Dermatology www.jidonline.org 2193
ORIGINAL ARTICLE
Received 4 August 2008; revised 24 December 2008; accepted 15 January
2008; published online 5 March 2009
1Department of Dermatology, Medical University of Vienna, Vienna, Austria;
2Department of Dermatology, University Hospital Schleswig-Holstein,
University of Kiel, Kiel, Germany and 3Centre de Recherches et
d’Investigations Epidermiques et Sensorielles, Neuilly-sur-Seine, France
Correspondence: Dr Leopold Eckhart, Department of Dermatology, Medical
University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria.
E-mail: leopold.eckhart@meduniwien.ac.at
Abbreviations: Ab, antibody; CFUs, colony-forming units; DEPC,
diethylpyrocarbonate; KCs, keratinocytes; PBS, phosphate-buffered saline;
qRT-PCR, quantitative real-time PCR; RI, ribonuclease inhibitor; RNase,
ribonuclease; SC, stratum corneum; TSB, tryptic soy broth
et al., 2002; Iyer et al., 2005; Johnson et al., 2007). RI has
been shown to inhibit the enzymatic activity of RNases, as
well as the antiretroviral activity of RNase 2 (Domachowske
and Rosenberg, 1997) and the angiogenic activity of RNase 5
(Shapiro and Vallee, 1987). By contrast, the killing activity of
RNase 3 toward microfilaria and trypanosomes is not blocked
by RI (Molina et al., 1988; Hamann et al., 1990).
Here, we have investigated the regulation of RNase–RI
interactions in the outer layers of the epidermis. We show
that in vitro, the ribonuclease and antimicrobial activities of
RNase 5 and RNase 7, which are both expressed by KCs and
present in the SC, are sensitive to RI. Despite the fact that,
similar to RNase 5 and RNase 7, RI is also upregulated during
terminal KC differentiation, it is virtually absent from normal
SC. Co-incubation of RI and SC extracts revealed the
existence of SC proteolytic activity that is able to degrade
RI. We propose that by degrading RI, proteases of the SC
contribute to the antimicrobial defense of the skin.
RESULTS
Epidermal KCs express RNases 1, 4, 5, and 7, as well as RI
To provide the basis for a better understanding of the
potential roles of RNase–RI interactions in the skin, we
determined the mRNA expression profile of RNases 1–8 and
of RI in cultured epidermal KCs. RNases 1, 4, 5, and 7, as
well as RI were detected by reverse transcription-PCR,
whereas other RNases were not. RNases 4, 5, and 7 were
expressed in both proliferating (data not shown) and
differentiated KCs (Figure 1a). Differentiated KCs also
expressed RNase 1 splice variants, 2 (lower band, GenBank
acc. no. NM198234) and 4 (upper band, GenBank acc. no.
NM002933), which differ in the 50-untranslated region but
code for the same protein. For RNase 4, splice variant 2
(GenBank acc. no. NM002937) and for RNase 5, splice
variant 1 (GenBank acc. no. NM001145) could be amplified
(Figure 1a, upper panel). The identity of the PCR products
was determined by direct sequencing, and the integrity of the
assays for RNases 2, 3, 6, and 8, which were not detected at
the cDNA level, was confirmed by PCR amplification using
genomic DNA as a template (Figure 1a, lower panel). The
expression of RNases 9–13 was not investigated, as they do
not have all the elements to support ribonuclease activity
(Dyer and Rosenberg, 2006).
Focusing on RNases with antimicrobial activities (Harder
and Schro¨der, 2002; Hooper et al., 2003), we investigated the
regulation of RNase 5 and RNase 7 during KC differentiation.
By quantitative real-time PCR (qRT-PCR), we found that the
expressions of RNase 5 and RNase 7 mRNA were upregu-
lated four- and nine-fold, respectively, in differentiated
cultures compared with proliferating KCs (Figure 1b and c).
The concentrations of secreted RNase 5 and RNase 7 proteins
were determined by ELISA. Culture medium conditioned by
differentiated KCs for 24 hours contained approximately four-
and six-fold higher levels of RNase 5 and RNase 7,
respectively, than medium conditioned by proliferating cells
(Figure 1d and e). As the cell biomass, estimated by protein
quantification, was elevated by only 1.7-fold (data not
shown), these data show that the production of RNase 5
and RNase 7 was upregulated during differentiation of KCs.
The absolute concentration of secreted RNase 5 was smaller
than that of RNase 7 (Figure 1d and e). Similarly, the amount
of soluble RNase 5 that we could extract from the SC of
human heels, that is, 57±38 pg per mg SC, was much smaller
than the amount of RNase 7 that has been extracted from the
SC of different donors, that is, up to 6,000 pg per mg SC
(Harder and Schro¨der, 2002).
RI is expressed in the epidermis but is absent in the SC
We next investigated the expression of RI in human skin
(n¼5) by immunohistochemistry. RI was expressed in all
viable layers of the epidermis, with the strongest expression
being detectable in the uppermost layers of the epidermis. By
contrast, RI immunoreactivity was not detectable in the SC
(Figure 2a).
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Figure 1. KCs express RNases 1, 4, 5, and 7, as well as RI. Total RNA was
isolated from proliferating (prolif.) and differentiated (diff.) human KC cultures
and reverse-transcribed to cDNA. (a) cDNAs of diff. KCs were amplified by
PCRs specific for RNases 1–8 and for RI. Amplicons were separated on a 1.5%
agarose gel containing ethidium bromide. To confirm the efficiency of each
PCR, reactions with the same primer combinations were performed on
genomic DNA. In these control reactions, exonic and intronic sequences of
all genes except RNases 4 and 5, in which the primer annealing sites are
separated by a long intron, were successfully amplified (lower panel). (b)
RNase 5 and (c) RNase 7 expressions in KCs were determined by qRT-PCR.
Relative gene expression levels were normalized to the expression of the
housekeeping gene ALAS. The mean values of the expression levels relative to
the expression level in proliferating cells are displayed. Secretion of (d) RNase
5 and (e) RNase 7 of proliferating and differentiated KCs was determined by
ELISAs. Data represent the mean±SD. bp, base pair.
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The expression of RI during KC differentiation in vitro was
investigated by qRT-PCR and western blot analysis. RI was
upregulated at both the mRNA (Figure 2b) and protein levels
(Figure 2c) in differentiated versus proliferating KCs.
RI blocks ribonuclease activity of SC as well as the
antimicrobial activity of RNase 5 and RNase 7
In accordance with an earlier report (Probst et al., 2006), we
readily detected ribonuclease activity in SC extracts. The
addition of recombinant human RI virtually abrogated this
activity, suggesting that the RNases of the SC can be bound
and neutralized by RI (Figure 3a). Moreover, RI blocked the
ribonuclease activity of recombinant RNase 5 and purified
RNase 7 from SC in vitro, confirming the functionality of our
proteins (Figure 3b).
We next tested whether RI is also able to interfere with the
antimicrobial activities of RNase 5 and RNase 7 against
C. albicans and E. faecium, respectively (Harder and
Schro¨der, 2002; Hooper et al., 2003). In the absence of RI,
antimicrobial activity of RNase 5 and RNase 7 strongly
reduced the colony-forming units (CFUs) of C. albicans and
E. faecium, respectively. Pre-incubation with RI strongly
suppressed the antimicrobial activity of both RNases,
whereas the addition of RI alone had no effect on either
microbe (Figure 4a and b). These results show that RI not only
blocks ribonuclease activity but also suppresses the anti-
microbial activity of RNase 5 and RNase 7, which to our
knowledge has not been reported earlier.
The antimicrobial effect of RNase 5 is blocked by chemical
inhibitors of its ribonuclease activity
As RI interacts with a large portion of the surface of target
RNases (Papageorgiou et al., 1997) and not specifically with
the catalytic center, the blockade of antimicrobial activities
of RNase 5 and RNase 7 may be mediated by interference
with the RNase catalytic activity or by sterical blockade of a
bactericidal protein domain. The antimicrobial activity of
RNase 7 is mediated by a cluster of lysine residues and does
not depend on catalytic activity (Huang et al., 2007). Amino-
acid sequence alignment showed that the residues critical for
the antibacterial activity of RNase 7 are not conserved in
RNase 5 (Figure S1). Therefore, we hypothesized that RNase
5 utilizes a different mechanism, possibly involving its
ribonucleolytic activity to kill Candida. RNase 5 was pre-
incubated with two chemical inhibitors of its ribonuclease
activity, namely, diethylpyrocarbonate (DEPC) (Shapiro et al.,
1987) and benzopurpurin B (Jenkins and Shapiro, 2003). As
expected, both substances inhibited the degradation of RNA
by RNase 5 in a dose-dependent manner (Figure 5a and b). In
close correlation with this blockade, both DEPC and
benzopurpurin B also inhibited the candida–cidal activity of
RNase 5 (Figure 5c and d), indicating that the antimicrobial
effect of RNase 5 depends on its ribonucleolytic activity.
Anti-RI Isotype ctrl.
RI expression
10
8
6
4
2
0
Prolif. Diff.
MW
(kDa)
55
36
Pr
ol
if.
D
iff
.
Pr
ol
if.
D
iff
.
R
el
at
ive
 m
R
N
A
ex
pr
es
sio
n
Figure 2. RI is expressed in the epidermis and in cultured KCs. (a) RI was
detected by immunohistochemistry in normal human skin. An isotype
antibody was used as negative control (ctrl.). The outer border of the SC is
marked by a dotted line. Bars¼ 40 mm. (b) qRT-PCR of RI in proliferating
(prolif.) and differentiated (diff.) KCs. Relative gene expression levels were
normalized to the expression of the housekeeping gene ALAS. Data represent
the mean±SD. (c) Western blot analysis of RI in prolif. and diff. KCs (left
panel). Ponceau staining of the membrane served as loading control of protein
lysates (right panel). MW, molecular weight; RI, ribonuclease inhibitor.
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Figure 3. Ribonuclease activities of SC extract, RNase 5, and RNase 7 are
blocked by RI. (a) SC extract (30 ng), (b) RNase 5 (25 ng), and RNase 7 (5 ng)
were pre-incubated with or without RI (30U for SC extract and 40U for
RNase 5 and RNase 7). Subsequently, the mixtures were incubated with total
RNA (1.5 mg) prepared from KCs as described in the Materials and Methods
section. Thereafter, the samples were electrophoresed through an RNase-free
agarose gel containing ethidium bromide. Positions of the 28S, 18S, and
5S rRNA bands are indicated. U, units.
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To further characterize the antimicrobial potential of
RNase 5, we also tested Pseudomonas aeruginosa, E. coli,
methicillin-resistant Staphylococcus aureus, Enterococcus
faecium, and group A Streptococcus for their sensitivity
toward RNase 5 treatment. However, among the microorgan-
isms investigated, RNase 5 was only effective in killing C.
albicans (Figure S2). To evaluate whether enhancement of the
expression of RNase 5 might contribute to the control of its
antimicrobial activity, KCs were stimulated with heat-
inactivated C. albicans or with the proinflammatory cyto-
kines, IL-1a and IL-6. Neither treatment altered the expres-
sion of RNase 5 in KCs (Figure S3). Similarly, the expression
of the RNase 5 inhibitor, RI, was not changed by proin-
flammatory stimuli (Figure S3).
RI is degraded by SC extract
As immunohistochemistry suggested that RI, although present
in the viable epidermal layers, was absent from SC (Figure
2a), we extracted proteins from the total epidermis and from
SC alone and performed western blot analysis. RI was
detected in lysates of the epidermis but, confirming the
immunohistochemistry data, was absent in SC extracts
(Figure 6a). The integrity of SC extract was confirmed by
western blot analysis of caspase-14, which was readily
detectable in its mature form (Figure 6a) (Fischer et al., 2004).
The fact that only the viable layers of the epidermis but not
the SC contained RI, indicated the existence of a mechanism
to eliminate RI during conversion of KCs into corneocytes. To
investigate this hypothesis, recombinant human RI was co-
incubated with SC extracts and then analyzed by western
blot. Under these conditions, RI protein was degraded, with
an intermediate cleavage product of RI being detectable
(Figure 6b). Incubation of RI alone with the extraction buffer
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Figure 4. RI inhibits antimicrobial activity of RNase 5 and RNase 7. (a)
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addition, C. albicans or E. faecium was treated with buffer and RI only. The
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untreated controls (100%). Data represent the mean of triplicates±SD. CFU,
colony-forming units.
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Figure 5. Antimicrobial effect of RNase 5 depends on its ribonuclease activity. (a) Ribonuclease activity of RNase 5 (0.6 mM) was tested in the
presence of diethylpyrocarbonate (DEPC) or (b) benzopurpurin B (BP) as described in the Materials and Methods section. Positions of the 28S, 18S, and
5S rRNA bands are indicated. (c) RNase 5 (0.2 mM) was pre-incubated with DEPC or (d) BP and thereafter tested for its ability to inhibit the growth of
C. albicans. The results are displayed as the percentage of the remaining CFUs in relation to only DEPC- or BP-treated controls (100%). Data represent
the mean of triplicates±SD.
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showed the stability of the protein under assay conditions. To
investigate the types of enzymes that are responsible for RI
degradation, SC extracts were pretreated with various
protease inhibitors (that is, aprotinin for serine proteases,
leupeptin for thiol proteases, EDTA and GM6001 for
metalloproteases, and a protease inhibitor cocktail (EDTA
free) for serine and cysteine proteases) and then analyzed for
their ability to degrade RI. The inhibitor cocktail, as well as
aprotinin and EDTA, inhibited proteases from degrading RI
(Figure 6b). It can be noted that EDTA was not effective at a
concentration that is considered sufficient to block metallo-
proteases, but only at a concentration at which EDTA also
interferes with the activity of some serine proteases (Beynon
and Bond, 2001). The metalloprotease-specific inhibitor,
GM6001, showed virtually no inhibition. This inhibition
profile suggested that serine proteases are mainly accoun-
table for RI degradation by SC extracts. In contrast to RI,
recombinant RNase 5 was stable when co-incubated with SC
extracts (Figure S4).
DISCUSSION
In this study, we have explored the expression of all
functional members of the RNase A superfamily, as well as
that of RI in epidermal KCs, and propose that differential
breakdown of RI during SC formation contributes to the
antimicrobial activity of the skin surface. Our expression
screening showed that four members of the RNase A family
are expressed by KCs. Two of these RNases, namely, RNase 5
and RNase 7, act as antimicrobial proteins, whereas no such
activity has been reported for RNase 1 and RNase 4. This
study shows the presence of RNase 5 in human SC and
thereby establishes another antimicrobial factor of the skin
defense against microbes. Similar to RNase 7, RNase 5 was
upregulated during differentiation. However, proinflamma-
tory or microbial inducers of expression could thus far be
identified for RNase 7 only (Harder and Schro¨der, 2002). The
rate of production of RNase 7 was approximately five times
higher than that of RNase 5 in cultured KCs, and much higher
amounts of RNase 7 than RNase 5 could be extracted from
human SC, indicating that RNase 7 contributes more to the
ribonucleolytic and antimicrobial activities of the skin
surface. Nevertheless, it is conceivable that the local
concentration of RNase 5, within distinct SC microcompart-
ments, may be sufficient for effective antimicrobial activity.
Importantly, the antimicrobial activity spectra of RNase 5
and RNase 7 appear to differ significantly. In particular,
C. albicans is killed by low concentrations of RNase 5
(Hooper et al., 2003; this study) but much less effectively by
RNase 7 (Harder and Schro¨der, 2002), whereas several
bacteria are killed by RNase 7 (Harder and Schro¨der, 2002)
and not by RNase 5 (this study). The relative contribution of
RNase 5 to the innate immune defense of the skin, which is
mediated by a plethora of peptides and other substances
(Schro¨der and Harder, 2006), remains to be determined in
future studies.
Our study provides a characterization of endogenous RI in
the epidermis and, importantly, extends its range of functions
to the inhibition of RNase antimicrobial activities. Both the
candida–cidal activity of RNase 5 and the enterococcus–cidal
activity of RNase 7 were effectively blocked by recombinant
RI. Earlier reports have shown that RI suppresses the
ribonuclease activity, which is low compared with other
members of the RNase A family, and the angiogenic activity
of RNase 5 (Shapiro et al., 1986; Shapiro and Vallee, 1987;
Papageorgiou et al., 1997; Maeda et al., 2002; Iyer et al.,
2005; Johnson et al., 2007). Two small chemical substances,
DEPC and benzopurpurin B, which inhibit the catalytic
activity of RNase 5, also suppressed its antimicrobial activity.
The binding site of benzopurpurin B on RNase 5 has been
determined (Jenkins and Shapiro, 2003), whereas the various
RNase 5 subsites, likely to be targeted by DEPC through the
modification of lysine and histidine residues, have not been
investigated for their individual contribution to the inhibitory
effect of DEPC. Therefore, it appears likely that RI suppresses
the antimicrobial function of RNase 5 by inhibiting its
catalytic center. However, further studies using point-
mutated variants of RNase 5 are required to substantiate this
hypothesis.
Although the antimicrobial activity of RNase 7 does not
depend on ribonucleolytic activity (Huang et al., 2007), our
data show that it is suppressed by RI. There are two possible
explanations for this finding: (1) It is possible that RI, which
has a horseshoe-like shape and binds RNases within its
concave cavity, masks the amino-acid residues responsible
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for antimicrobial action. (2) The interaction of RI with RNase
1 has recently been shown to induce conformational changes
of RNase 1 (Johnson et al., 2007). As the interaction of RI and
RNase 7 is likely to occur in a similar manner, a conforma-
tional change might also abrogate the antimicrobial activity
of RNase 7.
The finding that RI is expressed strongly in the uppermost
layers of the epidermis but is absent in SC, and the fact that
SC contains ribonuclease activity and antimicrobial activity
of RNase 7 (Harder and Schro¨der, 2002), indicated that a
physiological mechanism exists to prevent the inhibition of
skin surface ribonuclease functions. In support of this
hypothesis, the results of our co-incubation experiments
using recombinant RI and SC extract showed degradation of
RI. Our finding that aprotinin blocked the degradation of RI
indicates that this breakdown is mediated by serine proteases,
such as SCTE (SC tryptic enzyme, kallikrein 5) or SCCE (SC
chymotryptic protease, kallikrein 7). EDTA, which scavenges
divalent cations, also blocked the reaction; however, only
when it was used at a concentration higher than that required
to block metalloproteases but sufficient to also inhibit some
serine proteases (Beynon and Bond, 2001). Further studies are
necessary to determine the molecular identity of the RI-
degrading protease(s).
The proteolysis of RI by SC proteases establishes a role of
proteases in the antimicrobial defense function of the skin.
Conceptually, this control mechanism resembles the control
of the pro-apoptotic DNase, caspase-activated DNase (CAD)/
DNA fragmentation factor B (DFFB) by the inhibitor of CAD
(ICAD)/DNA fragmentation factor A (DFFA). ICAD inhibits
CAD unless it is cleaved by the cysteine protease caspase-3
(Sakahira et al., 1998). It remains to be investigated whether
proteolysis of RI enhances the breakdown of cellular RNAs
during differentiation-associated programmed cell death of
KCs. Irrespective of this potential role in cellular remodeling,
breakdown of RI appears to facilitate the activities of RNase
after corneocyte formation. A more direct dependence on
proteases of protein activation in the SC has been shown for
cathelicidin, which is converted into the antimicrobial
peptide, LL-37, by the action of the serine proteases,
kallikrein 5 (SCTE) and kallikrein 7 (SCCE) (Yamasaki et al.,
2006). The processing of cathelicidin by these proteases does
not require a distinct stimulus and leads to the constitutive
presence of LL-37 on the skin surface (Yamasaki et al., 2006).
Similarly, the proteolytic degradation of RI is likely to occur
in a constitutive manner. Taken together, the disturbance of
SC proteolytic activities, either caused by genetic defects or
by environmental influences, may compromise antimicrobial
skin defense.
In summary, this study identifies RNase 5 as a component
of the innate immune system of the skin and reveals an
additional level of the regulation of antimicrobial RNases in
human SC, that is, the removal of their inhibitor by proteases.
MATERIALS AND METHODS
Cell culture
Human primary KCs prepared from neonatal foreskin were obtained
from Clonetics (San Diego, CA) and cultured in serum-free
keratinocyte growth medium (Clonetics) as described earlier (Rendl
et al., 2002). Third-passage KCs were cultured in 12-well tissue
culture plates (Corning Incorporated, Corning, NY) and used at a
confluence of 60–70% (designated as proliferating) or maintained for
4 days after reaching confluence (designated as differentiated) by
replacing the medium every 24 hours. The differentiation state of
KCs was confirmed by determination of the differentiation marker,
filaggrin. Cultures were grown in triplicates. For in vitro stimulation,
recombinant IL-1a and IL-6 (R&D Systems, Minneapolis, MN) were
used.
RNA isolation, reverse transcription, and PCR
RNA was isolated using TRIzol Reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. cDNAs were synthe-
sized as described earlier (Abtin et al., 2008). Briefly, RNA was
reverse-transcribed with murine leukemia virus reverse transcriptase
using the Gene Amp RNA PCR kit (Applied Biosystems, Foster City,
CA) and oligo dT primers (Roche Diagnostics, Basel, Switzerland).
cDNA sequences of the genes under investigation were obtained
from the GenBank. Primers were designed using the PRIMER3
software from the Whitehead Institute for Biomedical Research
(Cambridge, MA). The following forward (F) and reverse (R) intron-
spanning primers were synthesized by VBC Genomics (VBC
Genomics, Vienna, Austria):
RNase 1: F, 50-GATTGCAGAAACTGGCCTTC-30 and R, 50-CTG
GGGGAACTGTCTGAGTC-30; RNase 2: F, 50-CTGAACCCCAGAAC
AACCAG-30and R, 50-GAGCCCAGGTAAACTGTGGA-30; RNase 3:
F, 50-AACAACCAGCTGGATCAGTTC-30 and R, 50-CCACTGAGCCCTCGTA
AACT-30; RNase 4: F, 50-AGAAGCGGGTGAGAAACAAA-30 and R,
50-AGTAGCGATCACTGCCACCT-30; RNase 5: F, 50-AGAAGCGGG
TGAGAAACAAA-30 and R, 50-TGTGGCTCGGTACTGGCATG-30;
RNase 6: F, 50-ATACACACAGGGCTCGAAGG-30 and R, 50-GGAC
ACACTGGTCCCCATAG-30; RNase 7: F, 50-GAGTCACAGCACGAA
GACCA-30 and R, 50-GGCTGCATGTGCTGAATTT-30; RNase 8: F,
50-CAGTGGTTTAAAACTCAGCATG-30 and R, 50-ACTATGTAAG
GTGTGTTCAGGT-30; RI: F, 50-CATCAGCTCTGCACTTCGAG-30
and R, 50-CAAGAGGTTGTCGCTGAGGT-30; b2-microglobulin
(B2M): F, 50-GATGAGTATGCCTGCCGTGTG-30 and R, 50-CAATCC
AAATGCGGCATCT-30; ALAS: F, 50-CCACTGGAAGAGCTGTGT
GA-30 and R, 50-ACCCTCCAACACAACCAAAG-30; and human
b-defensin-2 (hBD-2): F, 50-ATCAGCCATGAGGGTCTTGT-30 and
R, 50-GAGACCACAGGTGCCATTTT-30.
PCRs were performed in a volume of 50 ml containing 0.2 ml Red
Hot DNA polymerase (ABgene, Hamburg, Germany), 5 ml 10
reaction buffer IV (ABgene), 3ml MgCl2 (25mM), 4 ml dNTPs
(2.5mM), 2.5 ml of each primer (10 mM), and 31.8ml H2O. The PCR
included 5minutes at 94 1C for initial denaturing, followed by 38
cycles of 1minute at 94 1C, 45 seconds at 60 1C, 45 seconds at 72 1C,
and a final extension step at 72 1C for 5minutes. A negative control
(omitting cDNA) and a genomic DNA control PCR were performed
for each primer pair. Amplicons were subjected to electrophoresis in
a 1.5% agarose gel containing ethidium bromide.
qRT-PCR was performed by the LightCycler technology using the
Fast Start SYBR Green I kit for amplification and detection (Roche
Diagnostics). In all assays, cDNA was amplified using a standardized
program (10minutes denaturing step and 55 cycles of 5 seconds at
95 1C; 15 seconds at 65 1C and 15 seconds at 72 1C; melting point
analysis in 0.1 1C steps; final cooling step). Each LightCycler
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capillary was loaded with 1.5 ml DNA master mix, 1.8ml MgCl2
(25mM), 10.2 ml H2O, and 0.5 ml of each primer (10 mM). Relative
quantification of target gene expression and amplification efficien-
cies were performed using a mathematical model as described
earlier (Pfaffl, 2001). The expression of the target gene was
normalized to the expression of the housekeeping genes 5-
aminolevulinic acid synthase (ALAS) and/or B2M. Similar target
mRNA quantifications were obtained with either housekeeping gene
as standard. All qRT-PCRs were performed in triplicate. The
specificity of PCR reactions was confirmed by sequencing of the
PCR products. To identify RNase 1 variants, PCR products were
cloned into a pCR2.1-TOPO plasmid (Invitrogen) according to the
manufacturer’s instructions, and clones with different insert lengths
were sequenced.
Quantification of RNase 5 and RNase 7
Culture supernatants of KCs or SC extracts were depleted by
centrifugation of insoluble cell fragments and stored at 20 1C until
analysis. The concentration of RNase 5 was determined by ELISA
(R&D Systems) according to the manufacturer’s instructions.
The concentration of RNase 7 was determined with an
in-house RNase 7 ELISA, which has been developed using affinity-
purified goat RNase 7 antibodies (Abs), as will be described
elsewhere (Ko¨nten B, Gla¨ser R, Schro¨der JM, Harder J, unpublished
data).
Immunohistochemical analysis
Normal human skin was kindly provided by the Department of
Plastic Surgery (Medical University of Vienna, Austria). Immunohis-
tochemical analysis was performed on paraffin-embedded, formalin-
fixed skin sections (4mm) using the indirect immunoperoxidase
staining technique. Briefly, endogenous peroxidase activity of
sections were blocked by 0.3% H2O2/phosphate-buffered saline
(PBS) (pH 7.5) for 15minutes, washed with PBS, and then blocked
for 30minutes with 10% goat serum (PAA, Linz, Austria) diluted in
2% BSA/PBS. A polyclonal rabbit IgG anti-porcine RI Ab (kindly
provided by J. Hofsteenge, Friedrich Miescher-Institut, Basel,
Switzerland) was used. This Ab crossreacts with human RI (Blazquez
et al., 1996). Before immunolabeling with anti-RI or a rabbit IgG
isotype control (Santa Cruz Biotechnology, Santa Cruz, CA), the
sections were pretreated in ChemMate Target Retrieval Solution
(Dako Cytomation, Glostrup, Denmark) in a microwave oven for
2 5minutes at 500W. The anti-RI Ab and/or rabbit IgG isotype
control (both at 2 mgml1) were diluted in 2% BSA/PBS and applied
for 1 h on sections at room temperature. After washing in PBS, the
slides were incubated with biotinylated goat anti-rabbit IgG (1:100,
Vector Laboratories, Burlingame, CA) for 30minutes, washed in PBS,
and then exposed to StreptABComplex/HRP (Dako Cytomation) for
30minutes. The AEC (aminoethylcarbazole) substrate system (Dako
Cytomation) was used as the chromogen. The sections were
counterstained with hematoxylin.
Ribonuclease activity assay
Recombinant RNase 5 (R&D Systems), purified RNase 7 (Harder and
Schro¨der, 2002), or SC extract were pre-incubated with RI in 30mM
Tris (pH 7.5) containing 30mM NaCl in a total volume of 15 ml for
10minutes at 37 1C. Later, 1.5 mg of total RNA was added to the
reactions and incubated for 5minutes at 37 1C. Then, RNA loading
buffer (Fermentas, Glen Burnie, MD) was added, and the mixture
was heated for 5minutes at 65 1C, cooled on ice, and subsequently
electrophoresed through a 1% agarose gel containing ethidium
bromide.
Ribonuclease activity of RNase 5 was blocked by pre-incubation
with DEPC or benzopurpurin B (both from Sigma-Aldrich, Vienna,
Austria) in 10mM sodium phosphate buffer (pH 7.4) in a total volume
of 15 ml for 1 h at 37 1C.
Antimicrobial activity assay
C. albicans ATCC 90028 and a vancomycin-resistant E. faecium
clinical isolate were cultured overnight in tryptic soy broth
(TSB; Fluka, Buchs, Switzerland) with agitation at 37 1C,
subcultured the next day in fresh TSB, and then grown to optical
densities of 1.0 at 600 nm for E. faecium or at 450 nm for C. albicans.
Cells were washed twice with PBS and diluted to 104CFU per ml
in 10mM sodium phosphate buffer (pH 7.4) containing 1% (v/v) TSB.
Recombinant human RNase 5 (495% purity) was purchased
from R&D Systems and natural RNase 7 was purified from heel SC as
described earlier (Harder and Schro¨der, 2002). Recombinant human
RI was purchased from Ambion (Warrington, UK). The antimicrobial
activity was tested using a microdilution assay system. Tubes were
pre-incubated with 2% BSA/PBS for 1 hour at 37 1C and were then
rinsed with 10mM sodium phosphate buffer (pH 7.4) containing 1%
(v/v) TSB. As RI is provided with a storage buffer containing 20mM
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)-KOH
(pH 7.6), 50mM KCI, 5mM dithiothreitol, and 50% (v/v) glycerol,
the same buffer without RI was used in control reactions. For
inhibitory activity experiments, RNase 5 or RNase 7 was pre-
incubated with buffer alone or with RI in 10 ml volumes of 10mM
sodium phosphate buffer (pH 7.4) for 1 hour at 37 1C. An aliquot
of 100ml of the above-mentioned C. albicans or E. faecium
suspensions were then added and incubated for 3 hours at 37 1C
with agitation. Later, 20 ml aliquots were plated on Luria-Bertani agar
or Sabouraud-Dextrose agar for E. faecium and C. albicans,
respectively. The plates were incubated overnight at 37 1C. On the
following day, the number of CFUs was determined. The growth
inhibitory activities of the substances were calculated as follows:
(CFUs after incubation with substance)/(CFUs after incubation
without substance) 100, which represents the percentage of
remaining CFUs after treatment.
Antimicrobial activity and calculation of growth inhibition of
recombinant RNase 5 toward P. aeruginosa ATCC 27853, methi-
cillin-resistant S. aureus ATCC 33592, E. coli ATCC 35218, and a
clinical isolate of group A Streptococcus were performed as
described above, except that group A Streptococcus was grown in
TSB supplemented with 10% heat-inactivated fetal calf serum. To
determine CFUs, group A Streptococcus was plated on Columbia
agar, and P. aeruginosa, S. aureus, and E. coli were plated on Luria-
Bertani agar.
To test whether RNase 5 antimicrobial activity is blocked by
DEPC or benzopurpurin B, RNase 5 was pre-incubated in 10 ml
volumes of sodium phosphate buffer (10mM, pH 7.4) for 1 hour
at 37 1C with increasing concentrations of DEPC or benzopurpurin B.
An aliquot of 100 ml of the above-mentioned C. albicans suspension
was then added and incubated for 3 hours at 37 1C with
agitation. The growth inhibitory effect was calculated as described
above.
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SC extraction and incubation with RI
SC obtained from the heels of healthy volunteers was extracted with
100mM MES (2-(N-morpholino)ethanesulfonic acid) buffer pH 7.5
(Sigma-Aldrich). A ratio of 25mg SC to 200 ml buffer was used. SC
was homogenized in 1.5ml tubes (Eppendorf, Hamburg, Germany)
with a micropestle (Eppendorf) on ice (1–2minutes) and then
incubated for 1 h rotating at 4 1C. Thereafter, the tubes were
centrifuged with 15,000 g for 20minutes at 4 1C. Subsequently, the
supernatant was aliquoted and stored at 20 1C until analysis.
Sterility was verified by plating extracts on blood agar. Protein
concentrations of SC extracts were measured by the bicinchoninic
acid method (Pierce, Rockford, IL).
SC extract of 10 mg was co-incubated with 20U recombinant
human RI or 50 ng recombinant RNase 5 (R&D Systems) at 37 1C
with agitation. The final reaction volume was 30 ml. Aliquots of SC
were pre-incubated for 90minutes at 37 1C with the following
protease inhibitors: complete protease inhibitor cocktail (EDTA free),
leupeptin, aprotinin (all from Roche Diagnostic), EDTA pH 7.5
(Merck, Darmstadt, Germany), and GM6001 (Calbiochem Inc., La
Jolla, CA).
Western blot analysis
For analysis of RI expression, KC monolayer cultures were lysed in
1% Nonidet P-40 (Igepal CA-630; Sigma-Aldrich), and insoluble cell
debris was removed by centrifugation. The epidermis of skin biopsies
was separated by dispase II (30minutes at 37 1C; Roche Diagnostic)
from the dermis. Later, epidermis and/or heel scales were quick-
frozen with liquid nitrogen, ground in a mortar and suspended in
100mM MES (pH 7.5), and left rotating for 1 hour at 4 1C. Thereafter,
samples were centrifuged (15,000 g for 20minutes at 4 1C) and the
supernatant was aliquoted. The protein concentration was measured
by the bicinchoninic acid method (Pierce). Western blot analysis
was performed as described earlier (Mildner et al., 2006). Equal
loading of protein lysates was confirmed by Ponceau staining of the
membrane. Rabbit anti-RI Ab was used to detect RI protein (dilution
1:3,000). A peroxidase-conjugated goat anti-rabbit IgG Ab (dilution
1:10,000, Pierce) was used as a secondary Ab. Mouse anti-caspase-
14 (dilution 1:1,000; MBL, Naka-ku Nagoya, Japan) was used to
detect the proform and the active form of caspase-14 with a
secondary peroxidase-conjugated sheep anti-mouse IgG Ab (dilution
1:10,000, Amersham, Buckinghamshire, UK). To detect RNase 5, a
polyclonal goat Ab (R&D Systems) and a secondary peroxidase-
conjugated rabbit anti-goat (dilution 1:10,000, Dako Cytomation) Ab
were used. The membranes were developed using the Chemiglow
reagent (Alpha Innotech, San Leandro, CA) according to the
manufacturer’s instructions.
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SUPPLEMENTARY MATERIAL
Figure S1. Amino-acid sequence alignment of RNase 5 and RNase 7.
Figure S2. Antimicrobial activity of RNase 5 against potential skin pathogens.
Figure S3. RNase 5 and/or RI are not induced by IL-1a, IL-6, or C. albicans.
Figure S4. RNase 5 is not degraded by SC extract.
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